Page last updated: 2024-10-20

succinic acid and Paraganglioma

succinic acid has been researched along with Paraganglioma in 23 studies

Succinic Acid: A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)
succinic acid : An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle.

Paraganglioma: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)

Research Excerpts

ExcerptRelevanceReference
"Recent reports indicate that cancer-secreted succinate enhances cancer cell migration and promotes cancer metastasis by activating succinate receptor-1 (SUCNR-1)-mediated signaling and transcription pathways."2.82Cancer-derived extracellular succinate: a driver of cancer metastasis. ( Kuo, CC; Wu, JY; Wu, KK, 2022)
"Paraganglioma and pheochromocytoma are examples, whose etiology and therapy are complicated by the absence of representative cell lines or animal models."1.51Modeling succinate dehydrogenase loss disorders in C. elegans through effects on hypoxia-inducible factor. ( Braun, MM; Chen, C; Damjanac, T; Hu, J; Maher, LJ; Zhang, Y, 2019)

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (4.35)29.6817
2010's12 (52.17)24.3611
2020's10 (43.48)2.80

Authors

AuthorsStudies
Lamy, C1
Tissot, H1
Faron, M1
Baudin, E1
Lamartina, L1
Pradon, C1
Al Ghuzlan, A1
Leboulleux, S1
Perfettini, JL1
Paci, A1
Hadoux, J1
Broutin, S1
Gudgeon, N1
Munford, H1
Bishop, EL1
Hill, J1
Fulton-Ward, T1
Bending, D1
Roberts, J1
Tennant, DA1
Dimeloe, S1
Kuo, CC1
Wu, JY1
Wu, KK1
Branzoli, F3
Salgues, B3
Marjańska, M3
Laloi-Michelin, M3
Herman, P3
Le Collen, L3
Delemer, B3
Riancho, J3
Kuhn, E3
Jublanc, C3
Burnichon, N5
Amar, L5
Favier, J5
Gimenez-Roqueplo, AP5
Buffet, A5
Lussey-Lepoutre, C5
Bancel, LP1
Masso, V1
Dessein, AF1
Aubert, S1
Leteurtre, E1
Coppin, L1
Odou, MF1
Cao, CD1
Cardot-Bauters, C1
Pigny, P1
Wang, Y2
Liu, B1
Li, F1
Zhang, Y2
Gao, X1
Zhou, H1
Bellucci, A2
Drossart, T1
Fontaine, S2
Clement, O1
Benit, P2
Rustin, P2
Groussin, L1
Meatchi, T1
Tavitian, B2
Braun, MM1
Damjanac, T1
Chen, C1
Hu, J1
Maher, LJ3
Matlac, DM1
Hadrava Vanova, K1
Bechmann, N1
Richter, S2
Folberth, J1
Ghayee, HK1
Ge, GB1
Abunimer, L1
Wesley, R1
Aherrahrou, R1
Dona, M1
Martínez-Montes, ÁM1
Calsina, B1
Merino, MJ1
Schwaninger, M1
Deen, PMT1
Zhuang, Z1
Neuzil, J1
Pacak, K7
Lehnert, H1
Fliedner, SMJ1
Hirose, R1
Tsurutani, Y1
Sugisawa, C1
Inoue, K1
Suematsu, S1
Nagata, M1
Hasegawa, N1
Kakuta, Y1
Yonamine, M1
Takekoshi, K1
Kimura, N1
Saito, J1
Nishikawa, T1
Taïeb, D3
Eijkelenkamp, K1
Osinga, TE1
Links, TP1
van der Horst-Schrivers, ANA1
Rao, JU2
Engelke, UF1
Rodenburg, RJ1
Wevers, RA1
Eisenhofer, G3
Qin, N2
Kusters, B1
Goudswaard, AG1
Lenders, JW2
Hermus, AR1
Mensenkamp, AR1
Kunst, HP1
Sweep, FC1
Timmers, HJ2
Lendvai, N1
Pawlosky, R1
Bullova, P1
Patocs, A1
Veech, RL1
Imperiale, A2
Moussallieh, FM2
Sebag, F2
Brunaud, L2
Barlier, A2
Elbayed, K2
Bachellier, P2
Goichot, B2
Namer, IJ2
Peitzsch, M1
Rapizzi, E1
de Cubas, AA1
Schiavi, F1
Beuschlein, F1
Quinkler, M1
Opocher, G1
Mannelli, M1
Robledo, M1
Roche, P1
Battini, S1
Cicek, AE1
Loundou, A1
Stratakis, CA1
Her, YF1
Nelson-Holte, M1
Morin, A1
Janin, M1
Ottolenghi, C1
Zinzindohoué, F1
Autret, G1
Robidel, E1
Banting, B1
Cuenod, CA1
Halimi, P1
Fournier, L1
Hoekstra, AS1
Addie, RD1
Ras, C1
Seifar, RM1
Ruivenkamp, CA1
Briaire-de Bruijn, IH1
Hes, FJ1
Jansen, JC1
Corssmit, EP1
Corver, WE1
Morreau, H1
Bovée, JV1
Bayley, JP1
Devilee, P1
Zu, TJ1
Jia, MY1
Yuan, RT1
Bu, LX1
Yao, RY1
Hobert, JA1
Mester, JL1
Moline, J1
Eng, C1
Smith, EH1
Janknecht, R1

Reviews

4 reviews available for succinic acid and Paraganglioma

ArticleYear
Cancer-derived extracellular succinate: a driver of cancer metastasis.
    Journal of biomedical science, 2022, Nov-07, Volume: 29, Issue:1

    Topics: Extracellular Space; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Paragan

2022
The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Adrenal Gland Neoplasms; Citric Acid Cycle; Dioxygenases; Fumarates; Humans; Ketoglutaric Acids; Mut

2023
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.
    Trends in endocrinology and metabolism: TEM, 2017, Volume: 28, Issue:11

    Topics: Adrenal Gland Neoplasms; Catecholamines; Fluorodeoxyglucose F18; Humans; Paraganglioma; Phenotype; P

2017
Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
    Clinical genetics, 2020, Volume: 97, Issue:1

    Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Carcinoma, Renal Cell; Genetic Predisposition to Disease

2020

Other Studies

19 other studies available for succinic acid and Paraganglioma

ArticleYear
Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
    The Journal of clinical endocrinology and metabolism, 2022, 09-28, Volume: 107, Issue:10

    Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Germ-Line Mutation; Humans; Mutation; Paraganglioma; Phe

2022
Succinate uptake by T cells suppresses their effector function via inhibition of mitochondrial glucose oxidation.
    Cell reports, 2022, 08-16, Volume: 40, Issue:7

    Topics: Adrenal Gland Neoplasms; CD8-Positive T-Lymphocytes; Cytokines; Glucose; Humans; Paraganglioma; Pheo

2022
SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
    Endocrine-related cancer, 2023, 02-01, Volume: 30, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Germ-Line Mutation; Humans; Magnetic Resonance Spectroscopy; Mutat

2023
SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
    Endocrine-related cancer, 2023, 02-01, Volume: 30, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Germ-Line Mutation; Humans; Magnetic Resonance Spectroscopy; Mutat

2023
SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
    Endocrine-related cancer, 2023, 02-01, Volume: 30, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Germ-Line Mutation; Humans; Magnetic Resonance Spectroscopy; Mutat

2023
SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
    Endocrine-related cancer, 2023, 02-01, Volume: 30, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Germ-Line Mutation; Humans; Magnetic Resonance Spectroscopy; Mutat

2023
Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit.
    The Journal of clinical endocrinology and metabolism, 2023, 08-18, Volume: 108, Issue:9

    Topics: Adrenal Gland Neoplasms; Carcinogenesis; Cell Transformation, Neoplastic; Fumarates; Germ-Line Mutat

2023
Succinate detection using in vivo
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:6

    Topics: Adrenal Gland Neoplasms; Animals; Germ-Line Mutation; Humans; Magnetic Resonance Spectroscopy; Mice;

2020
Modeling succinate dehydrogenase loss disorders in C. elegans through effects on hypoxia-inducible factor.
    PloS one, 2019, Volume: 14, Issue:12

    Topics: Adrenal Gland Neoplasms; Amino Acids, Dicarboxylic; Animals; Animals, Genetically Modified; Caenorha

2019
Succinate Mediates Tumorigenic Effects
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: Animals; Humans; Mice; Mutation; Paraganglioma; Pheochromocytoma; Protein Subunits; Rats; Receptors,

2021
Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports.
    Journal of medical case reports, 2021, May-22, Volume: 15, Issue:1

    Topics: Adrenal Gland Neoplasms; Adult; Female; Humans; Japan; Mutation; Neoplasm Recurrence, Local; Paragan

2021
Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jul-15, Volume: 19, Issue:14

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Catecholamines; Electron Transport Complex II; Energy Me

2013
Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.
    Endocrinology, 2014, Volume: 155, Issue:1

    Topics: Adrenal Gland Neoplasms; Animals; Biomarkers, Tumor; Citric Acid Cycle; Female; Fumarates; Gene Expr

2014
A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Glutamic Acid; Humans; Metabolomics; Models, Biological; Paraganglioma; Succinate Dehydrogenase; Suc

2013
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:10

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Citric Acid Cycle; Female; Follow-Up Studies; Fuma

2014
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
    Neoplasia (New York, N.Y.), 2015, Volume: 17, Issue:1

    Topics: Female; Humans; Immunohistochemistry; Male; Metabolic Networks and Pathways; Metabolome; Metabolomic

2015
Oxygen concentration controls epigenetic effects in models of familial paraganglioma.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: 5-Methylcytosine; Animals; Case-Control Studies; Cytosine; Dioxygenases; DNA Methylation; Epigenesis

2015
In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Mar-01, Volume: 22, Issue:5

    Topics: Animals; Electron Transport Complex II; Genetic Predisposition to Disease; Germ-Line Mutation; Human

2016
Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers.
    Human molecular genetics, 2016, 09-01, Volume: 25, Issue:17

    Topics: Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 11; Cyclin-Dependent Kinase Inhibitor

2016
[The mutations of germline succinate dehydrogrnase subunit B (SDHB) in sporadic paragangliomas].
    Shanghai kou qiang yi xue = Shanghai journal of stomatology, 2011, Volume: 20, Issue:4

    Topics: DNA Mutational Analysis; Germ-Line Mutation; Humans; Mutation; Paraganglioma; Succinate Dehydrogenas

2011
Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals.
    Genetics in medicine : official journal of the American College of Medical Genetics, 2012, Volume: 14, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carboxylic Acids; Child; Child, Preschool; Female; Follo

2012
Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.
    Human molecular genetics, 2007, Dec-15, Volume: 16, Issue:24

    Topics: Cells, Cultured; Citric Acid Cycle; Dioxygenases; Enzyme Inhibitors; Humans; Jumonji Domain-Containi

2007